D
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Price:
10.87
USD
Market Closed
Market Cap:
$263.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
Intrinsic Value
Not Available for DMAA
There is not enough data to reliably calculate the intrinsic value for Drugs Made In America Acquisition Corp.
Do our valuations actually work? See backtest results .
Alternatives to DMAA
Fundamental Analysis
What Drugs Made In America Acquisition Does
Drugs Made In America Acquisition Corp is a special purpose acquisition company, or SPAC. It does not sell products or run a normal operating business. Its job is to raise cash from investors and then look for a private company to combine with, usually in or around the healthcare and pharmaceutical space suggested by its name.
- Headquarters
- United States of America US
- IPO date
- Jan 28, 2025
Financials
Efficiency
Earnings Waterfall
Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp